Literature DB >> 1739138

Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis.

H Noguchi1, G M Kephart, T V Colby, G J Gleich.   

Abstract

Eosinophilia has long been associated with endomyocardial fibrosis, but the involvement of the eosinophilia in fibrosis of other organs is unclear. To investigate this question, the authors tested whether tissue eosinophilia and eosinophil degranulation are present in syndromes associated with fibrosis. The authors used an indirect immunofluorescent technique to localize eosinophil granule major basic protein (MBP) in formalin-fixed, paraffin-embedded tissue specimens from 50 patients. Thirty-four specimens were obtained from patients with inflammatory fibrosis: 12 with idiopathic retroperitoneal fibrosis, seven with sclerosing mediastinitis, four with sclerosing cholangitis, and 11 with pulmonary fibrosis. The remaining 16 specimens were obtained from patients with noninflammatory fibrous proliferations: four with keloids, six with scars, three with Dupuytren's contracture and three with dense stromal fibrosis of the breast. Eosinophil infiltration and/or extracellular MBP deposition were observed in 28 of the 34 specimens (82%) from patients with inflammatory fibrosis, including 11 of the 12 cases of retroperitoneal fibrosis, five of the seven cases of sclerosing mediastinitis, all four cases of sclerosing cholangitis, and 8 of the 11 cases of pulmonary fibrosis. In contrast, eosinophil infiltration and MBP deposition were not observed in specimens from the 16 patients with noninflammatory fibrous proliferation (P less than 0.001). These results indicate that eosinophil infiltration and release of a granule protein, namely MBP, commonly occur in inflammatory fibrotic lesions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1739138      PMCID: PMC1886427     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Tissue eosinophilia and eosinophil degranulation in orbital pseudotumor.

Authors:  H Noguchi; G M Kephart; R J Campbell; J T Li; K M Leiferman; S D Trocme; G J Gleich
Journal:  Ophthalmology       Date:  1991-06       Impact factor: 12.079

2.  Comparison of antifading agents used in immunofluorescence.

Authors:  K D Krenik; G M Kephart; K P Offord; S L Dunnette; G J Gleich
Journal:  J Immunol Methods       Date:  1989-02-08       Impact factor: 2.303

3.  Extracellular deposition of eosinophil granule major basic protein in lymph nodes of patients with Hodgkin's disease.

Authors:  J H Butterfield; G M Kephart; P M Banks; G J Gleich
Journal:  Blood       Date:  1986-12       Impact factor: 22.113

4.  Eosinophil peroxidase is detectable with a monoclonal antibody in collagen bands of nodular sclerosis Hodgkin's disease.

Authors:  M Samoszuk; S Sholly; A L Epstein
Journal:  Lab Invest       Date:  1987-04       Impact factor: 5.662

5.  Eosinophil granule major basic protein in acute renal allograft rejection.

Authors:  R M Ten; G J Gleich; K E Holley; J D Perkins; V E Torres
Journal:  Transplantation       Date:  1989-06       Impact factor: 4.939

6.  Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease.

Authors:  P C Tai; S J Ackerman; C J Spry; S Dunnette; E G Olsen; G J Gleich
Journal:  Lancet       Date:  1987-03-21       Impact factor: 79.321

7.  Cellular events in the bronchi in mild asthma and after bronchial provocation.

Authors:  R Beasley; W R Roche; J A Roberts; S T Holgate
Journal:  Am Rev Respir Dis       Date:  1989-03

8.  Idiopathic retroperitoneal fibrosis (sclerosing retroperitonitis).

Authors:  B M Osborne; J J Butler; P Bloustein; G Sumner
Journal:  Hum Pathol       Date:  1987-07       Impact factor: 3.466

9.  Destruction of bloodstream forms of Trypanosoma cruzi by eosinophil granule major basic protein.

Authors:  F Kierszenbaum; S J Ackerman; G J Gleich
Journal:  Am J Trop Med Hyg       Date:  1981-07       Impact factor: 2.345

10.  Activation of platelets by eosinophil granule proteins.

Authors:  M S Rohrbach; C L Wheatley; N R Slifman; G J Gleich
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

View more
  45 in total

1.  Study of heteroserum-induced rat liver fibrosis model and its mechanism.

Authors:  Zhi-Gang Huang; Wei-Rong Zhai; Yue-E Zhang; Xiu-Rong Zhang
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

2.  Microwave & Magnetic (M2) Proteomics of a Mouse Model of Mild Traumatic Brain Injury.

Authors:  Teresa M Evans; Holly Van Remmen; Anjali Purkar; Swetha Mahesula; J Al Gelfond; Marian Sabia; Wenbo Qi; Ai-Ling Lin; Carlos A Jaramillo; William E Haskins
Journal:  Transl Proteom       Date:  2014-06-01

3.  Endomyocardial fibrosis: pathological and molecular findings of surgically resected ventricular endomyocardium.

Authors:  Silvia D'Andretta Iglezias; Luiz Alberto Benvenuti; Fiorella Calabrese; Vera Maria Cury Salemi; Ana Maria Gonçalves Silva; Elisa Carturan; Sergio Almeida de Oliveira; Gaetano Thiene; Thales De Brito
Journal:  Virchows Arch       Date:  2008-09-02       Impact factor: 4.064

4.  Eosinophil granule proteins expressed in ocular cicatricial pemphigoid.

Authors:  A Heiligenhaus; J Schaller; S Mauss; S Engelbrecht; J E Dutt; C S Foster; K P Steuhl
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

Review 5.  Eosinophils and disease pathogenesis.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Semin Hematol       Date:  2012-04       Impact factor: 3.851

6.  CCR3 Blockade Attenuates Eosinophilic Ileitis and Associated Remodeling.

Authors:  Joanne C Masterson; Eóin N McNamee; Paul Jedlicka; Sophie Fillon; Joseph Ruybal; Lindsay Hosford; Jesús Rivera-Nieves; James J Lee; Glenn T Furuta
Journal:  Am J Pathol       Date:  2011-09-23       Impact factor: 4.307

Review 7.  Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field.

Authors:  Peter Valent; Gerald J Gleich; Andreas Reiter; Florence Roufosse; Peter F Weller; Andrzej Hellmann; Georgia Metzgeroth; Kristin M Leiferman; Michel Arock; Karl Sotlar; Joseph H Butterfield; Sabine Cerny-Reiterer; Matthias Mayerhofer; Peter Vandenberghe; Torsten Haferlach; Bruce S Bochner; Jason Gotlib; Hans-Peter Horny; Hans-Uwe Simon; Amy D Klion
Journal:  Expert Rev Hematol       Date:  2012-04       Impact factor: 2.929

8.  Resected case of eosinophilic cholangiopathy presenting with secondary sclerosing cholangitis.

Authors:  Fumihiko Miura; Takehide Asano; Hodaka Amano; Masahiro Yoshida; Naoyuki Toyota; Keita Wada; Kenichiro Kato; Tadahiro Takada; Junichi Fukushima; Fukuo Kondo; Hajime Takikawa
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

9.  Effects of monoclonal antibodies to adhesion molecules on eosinophilic myocarditis in Toxocara canis-infected CBA/J mice.

Authors:  S Hokibara; M Takamoto; M Isobe; K Sugane
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

10.  Reversal of established CD4+ type 2 T helper-mediated allergic airway inflammation and eosinophilia by therapeutic treatment with DNA vaccines limits progression towards chronic inflammation and remodelling.

Authors:  Elizabeth R Jarman; Jonathan R Lamb
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.